Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by McKee Amy E, Director. Officer active across 1 company, notably Biocryst Pharmaceuticals INC. Cumulatively, 7 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €51k. Activity tracked since 7 June 2022. The latest transaction was disclosed on 29 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
7 of 7 declarations
Amy E. McKee is a Director at BIOCRYST PHARMACEUTICALS INC. She contributes to corporate governance and the strategic direction of the company. As a board member, she participates in important decision-making and oversight of BIOCRYST's operations. Her experience in the biopharmaceutical sector is an asset for the company.